Dan (@danj_h) 's Twitter Profile
Dan

@danj_h

Paramedic Practitioner • PCN Digital Transformation Lead • Digital Portfolio Manager GP Leadership Group • SI: Diabetes, Careplanning, MDT🪴 🏳️‍🌈

ID: 950823495759532032

calendar_today09-01-2018 20:16:01

1,1K Tweet

2,2K Followers

2,2K Following

Jason Killens KAM (@jasonkillens) 's Twitter Profile Photo

Today The Association of Ambulance Chief Executives has published a position paper setting out a future vision for NHS ambulance commissioning. Find out more and read the paper here: aace.org.uk/news/aace-publ…

Today <a href="/AACE_org/">The Association of Ambulance Chief Executives</a> has published a position paper setting out a future vision for NHS ambulance commissioning. 

Find out more and read the paper here: aace.org.uk/news/aace-publ…
Eric Topol (@erictopol) 's Twitter Profile Photo

When should you take your blood pressure medication? A new randomized trial shows no difference bedtime vs morning JAMA jamanetwork.com/journals/jama/…

When should you take your blood pressure medication?
A new randomized trial shows no difference bedtime vs morning <a href="/JAMA_current/">JAMA</a> 
jamanetwork.com/journals/jama/…
Dr Emma Nash🕷🇪🇺 🇬🇧 🇵🇱 (@dremmanash) 's Twitter Profile Photo

A message for Wes Streeting The push for GP access has unintended downsides. Increasing appointments delays processing of admin - like access to referrals & prescriptions. Fatigue from too many patient interactions (bearing in mind we mainly see the most complex now) risks

Dr. Rhonda Patrick (@foundmyfitness) 's Twitter Profile Photo

Just one hour of indoor aerobic exercise can boost circulating levels of active vitamin D by 35%. Vitamin D is stored in the body's fat tissue. In obesity, large fat stores can sequester vitamin D, leading to lower serum levels of the major circulating form, 25(OH)D, despite

Just one hour of indoor aerobic exercise can boost circulating levels of active vitamin D by 35%.

Vitamin D is stored in the body's fat tissue. In obesity, large fat stores can sequester vitamin D, leading to lower serum levels of the major circulating form, 25(OH)D, despite
Muthu Vaduganathan (@mvaduganathan) 's Twitter Profile Photo

#CONFIDENCE 1⃣ + 1⃣ = 2⃣ Remarkably, kidney protection with combination therapy mathematically identical to what would be expected based on each monotherapy Finerenone (0.68) * Empagliflozin (0.71) Combination (Expected if Fully Additive): 0.48 Combination (Observed): 0.48

#CONFIDENCE  1⃣ + 1⃣ = 2⃣

Remarkably, kidney protection with combination therapy mathematically identical to what would be expected based on each monotherapy

Finerenone (0.68) * Empagliflozin (0.71)

Combination (Expected if Fully Additive): 0.48

Combination (Observed): 0.48
Pablo Corral MD (@drpablocorral) 's Twitter Profile Photo

👉Aspirin in primary prevention? Maybe not for everyone. But definitely worth reconsidering for those with elevated Lp(a). This compelling article in The American Journal of Medicine challenges the current dogma: Lipoprotein(a) may redefine aspirin’s role in cardiovascular

👉Aspirin in primary prevention? Maybe not for everyone. 
But definitely worth reconsidering for those with elevated Lp(a).

This compelling article in The American Journal of Medicine challenges the current dogma: Lipoprotein(a) may redefine aspirin’s role in cardiovascular
Prof Kamlesh Khunti (@kamleshkhunti) 's Twitter Profile Photo

📉 Who responds best to tirzepatide? Post hoc SURPASS-4 analysis ✅ Glycaemic control sustained in 75–84% 🔑 Predictors: higher dose, shorter T2DM duration, better β-cell function, metformin use, no albuminuria ✅ ≥10% weight loss sustained in 80% diabetesjournals.org/diabetes/artic…

📉 Who responds best to tirzepatide?

Post hoc SURPASS-4 analysis 

✅ Glycaemic control sustained in 75–84%

🔑 Predictors: higher dose, shorter T2DM duration, better β-cell function, metformin use, no albuminuria

✅ ≥10% weight loss sustained in 80%

diabetesjournals.org/diabetes/artic…
PCDO Society (@pcdosociety) 's Twitter Profile Photo

Levemir insulin is to be discontinued, with an anticipated supply end date of December 2026. In response to this, ABCD and PCDO Society have published joint guidance to support clinicians in selecting and prescribing alternative insulins. 👉 eu1.hubs.ly/H0mmwQ80

Levemir insulin is to be discontinued, with an anticipated supply end date of December 2026.

In response to this, ABCD and PCDO Society have published joint guidance to support clinicians in selecting and prescribing alternative insulins.

👉 eu1.hubs.ly/H0mmwQ80
Michael "Mike" Albert, MD (@michaelalbertmd) 's Twitter Profile Photo

🚨BREAKING: FDA grants accelerated approval to Wegovy (semaglutide 2.4 mg injection) for treating adults with non‑cirrhotic metabolic dysfunction‑associated steatohepatitis (MASH) with moderate to advanced liver fibrosis - - - A Fourth Indication for Wegovy Wegovy’s FDA-approved

🚨BREAKING: FDA grants accelerated approval to Wegovy (semaglutide 2.4 mg injection) for treating adults with non‑cirrhotic metabolic dysfunction‑associated steatohepatitis (MASH) with moderate to advanced liver fibrosis
- - -
A Fourth Indication for Wegovy
Wegovy’s FDA-approved
Dr Anand Naik MD (@drarn93) 's Twitter Profile Photo

Thread: Major Changes in 2025 ACC/AHA #Hypertension Guidelines vs 2017 1⃣ BP Classification No change. HTN still defined as ≥130/80 mmHg. Normal <120/80, Elevated 120–129/<80, Stage 1: 130–139/80–89, Stage 2: ≥140/90

Ahmed Bennis (@drbennisahmed) 's Twitter Profile Photo

SGLT2 inhibitor therapy and lower incidence of iron deficiency anaemia in patients with type 2 diabetes: A retrospective cohort study from Germany SGLT2i therapy was associated with a lower incidence of IDA in T2DM patients compared to DPP-4i therapy. These findings suggest a

SGLT2 inhibitor therapy and lower incidence of iron deficiency anaemia in patients with type 2 diabetes: A retrospective cohort study from Germany

SGLT2i therapy was associated with a lower incidence of IDA in T2DM patients compared to DPP-4i therapy. These findings suggest a
Professor Chris Whitty (@cmo_england) 's Twitter Profile Photo

(1/9) A CMO data report on health trends and variation in England, 2025 provides a snapshot on health. I pull out some of the key data in the thread below. gov.uk/government/pub…

Rohan Paul (@rohanpaul_ai) 's Twitter Profile Photo

🚨 BAD news for Medical AI models. MASSIVE revelations from this Microsoft paper. 🤯 Current medical AI models may look good on standard medical benchmarks but those scores do not mean the models can handle real medical reasoning. The key point is that many models pass tests

🚨 BAD news for Medical AI models.

MASSIVE revelations from this <a href="/Microsoft/">Microsoft</a> paper.

🤯 Current medical AI models may look good on standard medical benchmarks but those scores do not mean the models can handle real medical reasoning.

The key point is that many models pass tests
Dr Steve Taylor (@drstevetaylor) 's Twitter Profile Photo

I spoke to Sky News this morning Raising expectations without any support GP online access is a good thing but it needs extra GPs & resources The 8am rush may reduce but there are no more appts or Hp time to offer, in fact less as a online forms are dealt with Safety vital

Prof Kamlesh Khunti (@kamleshkhunti) 's Twitter Profile Photo

📢 Semaglutide in non-overweight people with T2D 📊 Retrospective TriNetX study (BMI <25 kg/m²) 🩺 3-year outcomes •All-cause mortality: 6.1% vs 10.7% (HR 0.54, 95% CI 0.45–0.65) ✅ •AMI: NS •Stroke: NS •Adverse events: No significant difference 💡 Semaglutide associated

📢 Semaglutide in non-overweight people with T2D

📊 Retrospective TriNetX study (BMI &lt;25 kg/m²)
🩺 3-year outcomes

•All-cause mortality: 6.1% vs 10.7% (HR 0.54, 95% CI 0.45–0.65) ✅

•AMI: NS
•Stroke: NS
•Adverse events: No significant difference

💡 Semaglutide associated
Prof Kamlesh Khunti (@kamleshkhunti) 's Twitter Profile Photo

UTI is uncommon with SGLT2i - mycotic infections are common This study has important clinical implications ⚠️ After UTI, 1 in 3 patients stopped SGLT2i Discontinuation led to higher CV & renal risk, with no reduction in recurrent UTIs. 💡 Following UTI - continue SGLT2i

UTI is uncommon with SGLT2i - mycotic infections are common

This study has important clinical implications

⚠️ After UTI, 1 in 3 patients stopped SGLT2i 

Discontinuation led to higher CV &amp; renal risk, with no reduction in recurrent UTIs.

💡 Following UTI - continue SGLT2i
NHS England (@nhsengland) 's Twitter Profile Photo

Today we have published the Medium Term Planning Framework for NHS England, marking the beginning of a new way of working in the NHS. This is the most ambitious plan the NHS has published in a generation. Read more ➡️ england.nhs.uk/publication/me…

Today we have published the Medium Term Planning Framework for NHS England, marking the beginning of a new way of working in the NHS.

This is the most ambitious plan the NHS has published in a generation.

Read more ➡️ england.nhs.uk/publication/me…
Aravind Palraj (@rheumat_aravind) 's Twitter Profile Photo

🚨 “SGLT2 Inhibitors: The Unexpected Uric Acid Hack?” These glucose drugs don’t just lower sugar — they also drop uric acid levels by tweaking renal transporters & purine metabolism ⚡️ 💡 Mechanism = ↓ URAT1 / GLUT9 + ↑ excretion + ↓ production 📖 Packer M, JACC 2024

🚨 “SGLT2 Inhibitors: The Unexpected Uric Acid Hack?”

These glucose drugs don’t just lower sugar — they also drop uric acid levels by tweaking renal transporters &amp; purine metabolism ⚡️

💡 Mechanism = ↓ URAT1 / GLUT9 + ↑ excretion + ↓ production
📖 Packer M, JACC 2024